NEW YORK, Sept. 16 (GenomeWeb News) - Roche and ParAllele BioScience have begun a research collaboration to discover genes and genetic variations related to type 2 diabetes, the companies said today.
Under the terms of the collaboration, which will focus on identifying new drugs and diagnostics to for the disease, Roche will provide clinical samples and funding to support the study, while ParAllele will use its SNP discovery and SNP genotyping platforms to discover genetic variations in the samples that are most often associated with type 2 diabetes.
Roche plans to further evaluate associations found during the study in a variety of larger patient populations. The companies did not provide further details about the collaboration.
ParAllele, which has signed SNP-based research collaborations with Baylor College of Medicine and Merck, said that the Roche project is the first commercial study that combines its SNP discovery platforms with high-throughput genotyping.